You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

Lannett Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for LANNETT, and what generic and branded alternatives to LANNETT drugs are available?

LANNETT has one hundred and thirty-two approved drugs.

There is one tentative approval on LANNETT drugs.

Summary for Lannett

US Patents:	0
Tradenames:	97
Ingredients:	94
NDAs:	132
Patent Litigation for Lannett:	See patent lawsuits for Lannett
PTAB Cases with Lannett as petitioner:	See PTAB cases with Lannett as petitioner

Drugs and US Patents for Lannett

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lannett	LANORINAL	aspirin; butalbital; caffeine	TABLET;ORAL	086986-002	Oct 18, 1985		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Lannett Co Inc	METHADONE HYDROCHLORIDE	methadone hydrochloride	CONCENTRATE;ORAL	212093-001	Nov 2, 2020	AA	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Lannett Co Inc	DRONABINOL	dronabinol	CAPSULE;ORAL	201463-002	May 18, 2018		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Lannett Co Inc	SUMATRIPTAN	sumatriptan	SPRAY;NASAL	204841-001	Feb 19, 2016	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Lannett Co Inc	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	TABLET;ORAL	215565-007	Jul 8, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Lannett Co Inc	LORATADINE	loratadine	SYRUP;ORAL	077421-001	Jun 29, 2006		OTC	No	No		⤷ Try a Trial				⤷ Try a Trial
Lannett Co Inc	PILOCARPINE HYDROCHLORIDE	pilocarpine hydrochloride	TABLET;ORAL	077220-001	Oct 14, 2005	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for LANNETT drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.